Facts about ovarian cancer in Maysanian women

• Authors: Haider Saadoon Qasim Alhilf , Redha Alwan Hasan Alhashimi

Title variants

PL

Dane dotyczące raka jajnika ukobiet z irackiej prowincji Majsan

• Languages of publication: EN

Abstracts

EN

Background: Ovarian cancer is one of the commonest gynecologic malignancy. It is the most common cause of death due to gynecologic tumors, and accounts for 50% of deaths due to all gynecologic cancer types. Objectives: The aim was to discuss and assess ovarian cancer in Misan province and to underline its impact for increased awareness and interest in screening and early diagnosis by the determination of the prevalence rates among Maysanian women. Methods: The study lasted six months. During this period, we obtained a lot of data from records of the Al-Shifaa Oncology Center in Misan province, Iraq. Between September 2016 and February 2017, 50 cases of ovarian cancer from 282 gynecologic cancers were recorded. Complete history was obtained for every case. Results: The study showed that ovarian cancer constituted 17.73% of all types of cancer. It usually occurred in patients aged 60–70 years (30%). Women lived in urban areas 1.5 times more frequently than in rural areas. The most common histopathological type of ovarian cancer was ovarian serous carcinoma (46%). The most common stages were stage III and IV, accounting for 76%. Conclusion: Ovarian cancer is the third most common gynecologic cancer type. It was more common in women aged 60–70 years. Regarding the family history, the results were insignificant. The most common histopathological type of ovarian cancer in this study was ovarian serous carcinoma. The most common stages of the disease were advanced stages III and IV.

PL

Wstęp: Rak jajnika jest jednym z najczęstszych nowotworów złośliwych żeńskich narządów płciowych oraz główną przyczyną umieralności z powodu tych nowotworów – odpowiada za 50% zgonów wśród chorych z nowotworami kobiecego układu płciowego. Cele: Omówienie i ocena występowania raka jajnika w irackiej prowincji Majsan w celu zwiększenia świadomości i zainteresowania badaniami przesiewowymi i wczesnym rozpoznaniem choroby poprzez określenie częstości występowania omawianego nowotworu wśród kobiet zamieszkujących region Majsan. Metody: Badanie trwało sześć miesięcy. Uzyskano liczne dane z Centrum Onkologii Al-Shifaa w prowincji Majsan w Iraku. W okresie od września 2016 do lutego 2017 roku odnotowano 50 przypadków raka jajnika wśród ogółem 282 przypadków nowotworów narządów płciowych. Od każdej pacjentki zebrano pełny wywiad. Wyniki: Badanie wykazało, że rak jajnika stanowił 17,73% nowotworów. Rozpoznawano go zwykle u kobiet w wieku 60–70 lat (30%). Pacjentki częściej (o 1,5 razy) zamieszkiwały rejony wiejskie. Najczęstszym typem histopatologicznym był surowiczy rak jajnika (46%). Chorobę zwykle rozpoznawano w stadium III i IV, co stanowiło 76% przypadków. Wnioski: Rak jajnika to trzeci co do częstości nowotwór żeńskich narządów płciowych. Występował częściej u kobiet w wieku 60–70 lat. Wyniki dotyczące wywiadu rodzinnego nie były istotne. Najczęstszy typ histopatologiczny stanowił surowiczy rak jajnika. Chorobę rozpoznawano przeważnie w zaawansowanym stadium – III i IV.

Keywords

EN

Misan province; gynecologic malignancy; ovarian cancer; serous carcinom

Discipline

• MEDICINE: MEDICINE

• Publisher: Medical Communications
• Journal: Current Gynecologic Oncology
• Year: 2017
• Volume: 15
• Issue: 2
• Pages: 113–119

Contributors

author

Haider Saadoon Qasim Alhilf

• Department of Medicine, Faculty of Medicine, University of Misan, Misan, Iraq

author

Redha Alwan Hasan Alhashimi

• Department of Family Medicine, Faculty of Medicine, University of Misan, Misan, Iraq

References

• 1. National Cancer Institute: Defining Cancer. Available from: https://www.cancer.gov/types/ovarian [cited: 10 June 2014].
• 2. Konar H (ed.): DC Dutta’s Textbook of Gynecology. Including Contraception. 6th ed., Jaypee Mrothers Medical Publishers (P) Ltd, New Delhi 2013.
• 3. Prat J, Franceschi S: Cancers of the female reproductive organs. In: Stewart BW, Wild CP (eds.): World Cancer Report 2014. International Agency for Research on Cancer, World Health Organization, Lyon 2014.
• 4. National Cancer Institute: Ovarian Cancer Prevention. December 6, 2013. Available from: https://www.cancer.gov/types/ovarian/patient/ovarian-prevention-pdq [cited: 1 July 2014].
• 5. SEER: Cancer Stat Facts: Ovarian Cancer. The SEER, Surveillance Research Program, in NCI’s Division of Cancer Control and Population Sciences. Available from: https://seer.cancer.gov/ statfacts/html/ovary.html [cited: 18 June 2014].
• 6. Lozano R, Naghavi M, Foreman K et al.: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095–2128.
• 7. Jayson GC, Kohn EC, Kitchener HC et al.: Ovarian cancer. Lancet 2014; 384: 1376–1388.
• 8. Cancer Research UK: Ovarian cancer. Available from: http:// www.cancerresearchuk.org/about-cancer/ovarian-cancer/riskscauses [cited: 29 January 2015].
• 9. Abdel Aziz KK, Shehata MA, Abdel Ghany AE et al.: Retrospective study of epithelial ovarian cancer in the Oncology Department, Menoufia University. Menoufia Medical Journal 2014; 27: 650–656.
• 10. Hoffman BL, Schorge JO, Schaffer JI et al.: Epithelial ovarian cancer. In: Hoffman BL, Schorge JO, Schaffer JI et al. (eds.): Williams Gynecology. 2nd ed., McGraw-Hill, 2012: 853–878.
• 11. Seiden MV: Gynecologic malignancies. In: Longo DL, Kasper DL, Jameson JL et al. (eds.): Harrison’s Principles of Internal Medicine. 18th ed., McGraw-Hill, New York 2012: 810–816.
• 12. Serov SF, Scully RE, Sobin LH: International Histological Classification of Tumours, No. 9. Histological Typing of Ovarian Tumours. World Health Organization, Geneva 1973.
• 13. Prat J; FIGO Committee on Gynecologic Oncology: Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet 2014; 124: 1–5.
• 14. National Cancer Institute: Diagnosis, Grading, and Staging.
• 15. Vermorken JB: What is new in ovarian cancer chemotherapy. Ginekol Onkol 2003; 1: 43–50.
• 16. Bhosale P, Peungjesada S, Wei W et al.: Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels. Int J Gynecol Cancer 2010; 20: 936–944.
• 17. Al-Rawi KM: Introduction to a statistical. Dar Al-Kutob for distribution and press. 2nd ed., University of Mosul, Mosul, Iraq 2000.
• 18. Mostafa MF, El-etreby N, Awad N: Retrospective analysis evaluating ovarian cancer cases presented at the clinical oncology department, Alexandria University. Alexandria Journal of Medicine 2012, 48: 353–360.
• 19. Freedman LS, Al-Kayed S, Qasem MB et al.: Cancer registration in the Middle East. Epidemiology 2001; 12: 131–133.
• 20. Arab M, Noghabaei G: Ovarian cancer incidence in Iran and the world. Reports of Radiotherapy and Oncology 2013; 1: 69–72.
• 21. Paes MF, Daltoé RD, Madeira KP et al.: A retrospective analysis of clinicopathological and prognostic characteristics of ovarian tumors in the State of Espírito Santo, Brazil. J Ovarian Res 2011; 4: 14.
• 22. Alghamdi IG, Hussain II, Alghamdi MS et al.: Incidence rate of ovarian cancer cases in Saudi Arabia: an observational descriptive epidemiological analysis of data from Saudi Cancer Registry 2001–2008. Int J Womens Health 2014; 6: 639–645.
• 23. Cancer Research UK: Ovarian cancer incidence statistics. Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/ovarian-cancer/ incidence.
• 24. Taheri N, Fazel A, Mahmoodzadeh H et al.: Epidemiology of female reproductive cancers in Iran: results of the Gholestan Population-based Cancer Registry. Asian Pac J Cancer Prev 2014; 15: 8779–8782.
• 25. Bidziński M, Gawrychowski K, Krzakowski M: Diagnostics, treatment and follow-up after management of ovarian cancer. Ginekol Onkol 2003; 1: 29–42.
• 26. Sung PL, Chang YH, Chao KC et al.; Task Force on Systematic Review and Meta-analysis of Ovarian Cancer: Global distribution pattern of histological subtypes of epithelial ovarian cancer: a database analysis and systematic review. Gynecol Oncol 2014; 133: 147–154.
• 27. Modugno F, Ness RB, Wheeler JE: Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness. Ann Epidemiol 2001; 11: 568–574.
• 28. Karimi-Zarchi M, Mortazavizadeh SM, Bashardust N et al.: The clinicopathologic characteristics and 5-year survival rate of epithelial ovarian cancer in Yazd, Iran. Electron Physician 2015; 7: 1399–1406.

• Document Type: article